|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1099
|
|
pubmed:dateCreated |
1994-4-8
|
|
pubmed:abstractText |
The aim of our study is to evaluate the effects of a new combined association of percutaneous estradiol with oral micronized progesterone during 25 days/month and to confirm that a low dose of progesterone (100 mg/day) can adequately counteract endometrial proliferation induced by estradiol.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0031-2983
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
475-87
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8127629-Administration, Cutaneous,
pubmed-meshheading:8127629-Adult,
pubmed-meshheading:8127629-Aged,
pubmed-meshheading:8127629-Biopsy,
pubmed-meshheading:8127629-Endometrium,
pubmed-meshheading:8127629-Estradiol,
pubmed-meshheading:8127629-Estrogen Replacement Therapy,
pubmed-meshheading:8127629-Female,
pubmed-meshheading:8127629-Humans,
pubmed-meshheading:8127629-Menopause,
pubmed-meshheading:8127629-Middle Aged,
pubmed-meshheading:8127629-Mitosis,
pubmed-meshheading:8127629-Progesterone
|
|
pubmed:articleTitle |
[The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone].
|
|
pubmed:affiliation |
Institut de Pathologie, Strasbourg.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
